IP Library Granted Patent US 9,228,179
Granted Patent B2
US 9,228,179 · App. 13/769,655 · Granted Jan 5, 2016

Polymerase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,228,179
App. No.
13/769,655
Granted
Jan 5, 2016
Kind
B2
Abstract

An engineered DNA polymerase characterised in that the polymerase exhibits an enhanced ability to process nucleic acid in the presence of environmental and biological inhibitors compared to wild type DNA polymerase.

Claims (3)

1. An engineered polymerase consisting of the amino acid sequence of SEQ ID NO: 2 and exhibiting at least a two-fold enhanced ability compared to the ability of the wild type Thermus aquaticus polymerase to process nucleic acid in the presence of humic acid at a concentration between 5 and 20%.

2. An engineered polymerase consisting of the amino acid sequence of SEQ ID NO: 4 and exhibiting at least a two-fold enhanced ability compared to the ability of the wild type Thermus aquaticus polymerase to process nucleic acid in the presence of humic acid at a concentration between 5 and 20%.

3. A kit for amplifying nucleic acid comprising an isolated, engineered polymerase according to claim 1 or claim 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →